Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Total Current Liabilities (2020 - 2025)

Mirum Pharmaceuticals has reported Total Current Liabilities over the past 6 years, most recently at $205.8 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $205.8 million for Q4 2025, up 62.62% from a year ago — trailing twelve months through Dec 2025 was $205.8 million (up 62.62% YoY), and the annual figure for FY2025 was $205.8 million, up 62.62%.
  • Total Current Liabilities for Q4 2025 was $205.8 million at Mirum Pharmaceuticals, up from $160.4 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for MIRM hit a ceiling of $205.8 million in Q4 2025 and a floor of $29.0 million in Q2 2021.
  • Median Total Current Liabilities over the past 5 years was $69.7 million (2022), compared with a mean of $86.0 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 168.13% in 2021 and later fell 1.34% in 2022.
  • Mirum Pharmaceuticals' Total Current Liabilities stood at $42.6 million in 2021, then soared by 51.96% to $64.7 million in 2022, then soared by 34.51% to $87.1 million in 2023, then skyrocketed by 45.35% to $126.6 million in 2024, then skyrocketed by 62.62% to $205.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $205.8 million (Q4 2025), $160.4 million (Q3 2025), and $144.8 million (Q2 2025) per Business Quant data.